Ignacio Anegon was born in Uruguay in 1956. He received his M.D. degree from the Universidad de la Républica del Uruguay in 1982. Between 1979 and 1982, he worked in clinical immunology at the University Hospital. He did his postdoctoral work at the Immunology Department of the University Hospital of Barcelona between 1982 and 1985. His research was on the generation and characterization of monoclonal antibodies against human leukocytes as well as application of cytofluorimetry and monoclonal antibodies for typing human leukemias and lymphomas. Between 1985 and 1988, he worked as an Associate Scientist at the Wistar Institute, University of Pennsylvania, USA. His area of research was on Fc receptors and human NK cell biology with the use of cellular and molecular biology techniques. In 1988, he served as a Visiting Scientist at the Institut National de la Santé et de la Recherche Médicale (INSERM) in Nantes, France. In 1989, he obtained a permanent position at the INSERM. His research in France focused on transplantation immunology, mainly immunoregulation by dendritic cells and by CD8+ Tregs, and in functional genomics, mainly transfer using viral vectors and the generation of transgenic and knockout rats. He works now as the Director of research at the INSERM and as the Director of the INSERM unit 643. He serves also as the Scientific Director of the Nantes Rat Transgenesis Platform. He has published more than 155 papers, has edited 2 books, and serves as the Editor-in-Chief of the journal Current Gene Therapy (PubMed indexed).
Biography Updated on 3 May 2011